Glibenclamide | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Glibenclamide
Canada

Evonik

Contact Supplier

Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Glibenclamide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 15 USDMF, 9 CEP/COS, 4 JDMF, 6 EU WC, 1 KDMF, 6 NDC API, 13 Listed Suppliers, $ API Reference Price

25 API Suppliers
15 USDMF
9 CEP/COS
4 JDMF
6 EU WC
1 KDMF
6 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

9 API Suppliers

9 API Suppliers

FINISHED DOSAGE FORMULATIONS

181 FDF Dossiers, 83 FDA Orange Book, 26 Europe, 7 Canada, 2 Australia, 19 South Africa, 44 Listed Dossiers

181 FDF Dossiers
83 FDA Orange Book
26 Europe
7 Canada
2 Australia
19 South Africa
44 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1.25MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1.25MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 7 SPI Pharma, 2 Seqens, 5 DKSH, 2 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 27 BASF, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 43 Direct Compression, 37 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 30 Solubilizers, 26 Thickeners and Stabilizers, 26 Granulation, 21 Film Formers & Plasticizers, 20 Co-Processed Excipients, 19 Lubricants & Glidants, 18 Topical, 14 Parenteral, 11 Taste Masking, 9 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

86 Fillers, Diluents & Binders
49 Coating Systems & Additives
43 Direct Compression
37 Controlled & Modified Release
30 Disintegrants & Superdisintegrants
30 Solubilizers
26 Thickeners and Stabilizers
26 Granulation
21 Film Formers & Plasticizers
20 Co-Processed Excipients
19 Lubricants & Glidants
18 Topical
14 Parenteral
11 Taste Masking
9 Emulsifying Agents
8 Chewable & Orodispersible Aids
6 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 23 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
23 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 33 Finished Drug Prices

2 US Medicaid Prescriptions
33 Finished Drug Prices

MARKET PLACE

14 APIs, 5 FDF Dossiers

14 APIs
5 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 Others

4 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 85 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 2APOTEX INC

02 2Pharmascience Inc.

03 1SANIS HEALTH INC

04 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

7 All

01 5GLYBURIDE

02 2Glyburide

filter Dosage Form Reset all filters

7 All

01 7TABLET

filter Brand Name Reset all filters

7 All

01 1APO GLYBURIDE TAB 2.5MG

02 1APO GLYBURIDE TAB 5MG

03 1EUGLUCON

04 1GLYBURIDE

05 1PMS-GLYBURIDE

06 2TEVA-GLYBURIDE

List of Suppliers

Product Main Page

01

APOTEX INC

2024 ACI Convention

Not Confirmed

APOTEX INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO GLYBURIDE TAB 5MG

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 30/100/500

Approval Date :

Application Number : 1913662

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

2024 ACI Convention

Not Confirmed

APOTEX INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : APO GLYBURIDE TAB 2.5MG

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 30/100/500

Approval Date :

Application Number : 1913654

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : EUGLUCON

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 30/100/300/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Pharmascience Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-GLYBURIDE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 30/100/300/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

SANIS HEALTH INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : GLYBURIDE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number : 2350467

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TEVA CANADA LIMITED

2024 ACI Convention

Not Confirmed

TEVA CANADA LIMITED

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-GLYBURIDE

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 100/500/30UD

Approval Date :

Application Number : 1913670

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

TEVA CANADA LIMITED

2024 ACI Convention

Not Confirmed

TEVA CANADA LIMITED

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TEVA-GLYBURIDE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500/30UD

Approval Date :

Application Number : 1913689

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?